8:50 -10:20 a.m. Clinical Trial Designs for Evaluating Treatment Effect in Subpopulations
Clinical Trial Designs for Evaluating Treatment Effect in Subpopulations
Organizer:
H.M. James Hung
(Food and Drug
Administration, U.S.A.) Email: hsienming.hung@fda.hhs.gov & suejane.wang@fda.hhs.gov Chair: H.M. James Hung (Food and Drug Administration, U.S.A.) Email: hsienming.hung@fda.hhs.gov
|
||
8:50-9:20
|
Speakers:
Chin-Fu Hsiao National Health Research Institutes, Taiwan, R.O.C. Email: chinfu@nhri.org.tw Title: Use of Prior Information for Bayesian Evaluation of Bridging Studies
|
|
9:20-9:50
|
H.M. James Hung Office of Biostatistics, OTS/CDER, Food and Drug Administration, U.S.A. Email: hsienming.hung@fda.hhs.gov Title: Statistical Frameworks of Clinical Trial Design for Evaluating Treatment Effect in Subpopulations
|
|
9:50-10:20
|
Satoshi Morita Program in Health and Community Medicine, Nagoya University Graduate School of Medicine, Japan Email: smorita@med.nagoya-u.ac.jp Title: Case Study of a Clinical Trial for A Molecular Targeting Anti-Cancer Drug
|